Teva 5-asa Tablet (aka Mesalamine): Out Of Specification (stability - Dissolution)
Teva is recalling 5-ASA tablets (also called mesalamine) in Canada because the medication does not meet stability standards for how quickly it dissolves in the body. This is a Class I recall, meaning the product may cause serious adverse health consequences. The recall affects 5-ASA tablets distributed across Canada.
- Product
- Teva 5-ASA tablet (aka MESALAMINE)
- Reason
- Product quality
- Classification
- Class I
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2025-04-07
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/145d87b1-c768-419b-bf30-42bdccd49539